Certara Inc (CERT)

$16.08

+0.07

(+0.44%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $15.62
    $16.38
    $16.08
    downward going graph

    2.89%

    Downside

    Day's Volatility :4.67%

    Upside

    1.83%

    downward going graph
  • $11.81
    $19.87
    $16.08
    downward going graph

    26.55%

    Downside

    52 Weeks Volatility :40.56%

    Upside

    19.07%

    downward going graph

Returns

PeriodCertara IncSector (Health Care)Index (Russel 2000)
3 Months
-0.5%
6.4%
0.0%
6 Months
-2.31%
6.0%
0.0%
1 Year
-17.03%
8.5%
0.0%
3 Years
-36.74%
14.6%
-20.8%

Highlights

Market Capitalization
2.5B
Book Value
$6.58
Earnings Per Share (EPS)
-0.39
Wall Street Target Price
18.83
Profit Margin
-17.02%
Operating Margin TTM
-1.33%
Return On Assets TTM
1.24%
Return On Equity TTM
-5.74%
Revenue TTM
360.7M
Revenue Per Share TTM
2.27
Quarterly Revenue Growth YOY
7.000000000000001%
Gross Profit TTM
203.1M
EBITDA
89.7M
Diluted Eps TTM
-0.39
Quarterly Earnings Growth YOY
-0.14
EPS Estimate Current Year
0.43
EPS Estimate Next Year
0.52
EPS Estimate Current Quarter
0.1
EPS Estimate Next Quarter
0.11

Analyst Recommendation

Hold
    47%Buy
    52%Hold
    0
    0%Sell
Based on 17 Wall street analysts offering stock ratings for Certara Inc(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
9
9
8
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 17.1%

Current $16.08
Target $18.83

Company Financials

FY18Y/Y Change
Revenue
163.7M
-
Net Income
-33.3M
-
Net Profit Margin
-20.31%
-
FY19Y/Y Change
Revenue
208.5M
↑ 27.36%
Net Income
-8.9M
↓ 73.16%
Net Profit Margin
-4.28%
↑ 16.03%
FY20Y/Y Change
Revenue
243.5M
↑ 16.79%
Net Income
-49.4M
↑ 453.41%
Net Profit Margin
-20.28%
↓ 16.0%
FY21Y/Y Change
Revenue
286.1M
↑ 17.48%
Net Income
-13.3M
↓ 73.14%
Net Profit Margin
-4.64%
↑ 15.64%
FY22Y/Y Change
Revenue
335.6M
↑ 17.32%
Net Income
14.7M
↓ 211.04%
Net Profit Margin
4.39%
↑ 9.03%
FY23Y/Y Change
Revenue
354.3M
↑ 5.57%
Net Income
-55.4M
↓ 475.79%
Net Profit Margin
-15.62%
↓ 20.01%
Q4 FY22Q/Q Change
Revenue
86.6M
↑ 2.28%
Net Income
9.2M
↑ 133.08%
Net Profit Margin
10.59%
↑ 5.94%
Q1 FY23Q/Q Change
Revenue
90.3M
↑ 4.23%
Net Income
1.4M
↓ 85.2%
Net Profit Margin
1.5%
↓ 9.09%
Q2 FY23Q/Q Change
Revenue
90.5M
↑ 0.17%
Net Income
4.7M
↑ 246.54%
Net Profit Margin
5.2%
↑ 3.7%
Q3 FY23Q/Q Change
Revenue
85.6M
↓ 5.39%
Net Income
-49.0M
↓ 1140.48%
Net Profit Margin
-57.22%
↓ 62.42%
Q4 FY23Q/Q Change
Revenue
88.0M
↑ 2.84%
Net Income
-12.5M
↓ 74.56%
Net Profit Margin
-14.15%
↑ 43.07%
Q1 FY24Q/Q Change
Revenue
96.7M
↑ 9.82%
Net Income
-4.7M
↓ 62.4%
Net Profit Margin
-4.85%
↑ 9.3%
FY18Y/Y Change
Total Assets
1.1B
-
Total Liabilities
558.7M
-
FY19Y/Y Change
Total Assets
1.0B
↓ 1.37%
Total Liabilities
545.0M
↓ 2.45%
FY20Y/Y Change
Total Assets
1.3B
↑ 22.4%
Total Liabilities
447.3M
↓ 17.94%
FY21Y/Y Change
Total Assets
1.5B
↑ 19.09%
Total Liabilities
469.9M
↑ 5.06%
FY22Y/Y Change
Total Assets
1.6B
↑ 4.05%
Total Liabilities
493.3M
↑ 4.98%
FY23Y/Y Change
Total Assets
1.6B
↓ 0.62%
Total Liabilities
516.3M
↑ 4.67%
Q4 FY22Q/Q Change
Total Assets
1.6B
↑ 4.26%
Total Liabilities
493.3M
↑ 8.58%
Q1 FY23Q/Q Change
Total Assets
1.6B
↓ 0.39%
Total Liabilities
481.7M
↓ 2.34%
Q2 FY23Q/Q Change
Total Assets
1.6B
↑ 0.35%
Total Liabilities
475.0M
↓ 1.38%
Q3 FY23Q/Q Change
Total Assets
1.5B
↓ 2.89%
Total Liabilities
475.1M
↑ 0.01%
Q4 FY23Q/Q Change
Total Assets
1.6B
↑ 2.38%
Total Liabilities
516.3M
↑ 8.68%
Q1 FY24Q/Q Change
Total Assets
1.5B
↓ 1.33%
Total Liabilities
488.0M
↓ 5.48%
FY18Y/Y Change
Operating Cash Flow
11.6M
-
Investing Cash Flow
-73.9M
-
Financing Cash Flow
57.3M
-
FY19Y/Y Change
Operating Cash Flow
38.0M
↑ 228.03%
Investing Cash Flow
-9.5M
↓ 87.12%
Financing Cash Flow
-8.5M
↓ 114.82%
FY20Y/Y Change
Operating Cash Flow
44.8M
↑ 17.84%
Investing Cash Flow
-8.6M
↓ 9.51%
Financing Cash Flow
208.2M
↓ 2552.75%
FY21Y/Y Change
Operating Cash Flow
60.4M
↑ 34.76%
Investing Cash Flow
-269.9M
↑ 3034.25%
Financing Cash Flow
123.4M
↓ 40.74%
FY22Y/Y Change
Operating Cash Flow
92.5M
↑ 53.25%
Investing Cash Flow
-27.8M
↓ 89.69%
Financing Cash Flow
-7.4M
↓ 105.97%
Q4 FY22Q/Q Change
Operating Cash Flow
35.5M
↑ 47.88%
Investing Cash Flow
-12.6M
↑ 279.03%
Financing Cash Flow
-968.0K
↓ 27.98%
Q1 FY23Q/Q Change
Operating Cash Flow
10.0M
↓ 71.94%
Investing Cash Flow
-2.7M
↓ 78.32%
Financing Cash Flow
-850.0K
↓ 12.19%
Q2 FY23Q/Q Change
Operating Cash Flow
18.1M
↑ 81.36%
Investing Cash Flow
-11.7M
↑ 329.55%
Financing Cash Flow
-6.4M
↑ 655.29%

Technicals Summary

Sell

Neutral

Buy

Certara Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Certara Inc
Certara Inc
17.89%
-2.31%
-17.03%
-36.74%
-57.77%
Solventum Corp
Solventum Corp
4.3%
-20.98%
-20.98%
-20.98%
-20.98%
Veeva Systems Inc.
Veeva Systems Inc.
-0.88%
-12.48%
-8.24%
-43.42%
8.57%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
1.6%
7.77%
-2.65%
32.98%
32.98%
Healthequity Inc
Healthequity Inc
-12.27%
-2.08%
16.94%
-3.03%
-8.24%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Certara Inc
Certara Inc
100.92
NA
NA
0.43
-0.06
0.01
NA
6.58
Solventum Corp
Solventum Corp
NA
NA
NA
6.26
0.17
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
53.22
53.22
1.35
4.76
0.13
0.06
NA
30.25
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
23.38
23.38
20.11
4.27
0.22
0.06
0.0
16.23
Healthequity Inc
Healthequity Inc
84.29
84.29
2.29
2.19
0.04
0.03
NA
24.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Certara Inc
Certara Inc
Hold
$2.5B
-57.77%
100.92
-17.02%
Solventum Corp
Solventum Corp
Hold
$10.8B
-20.98%
NA
15.73%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$29.2B
8.57%
53.22
22.34%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$36.7B
32.98%
23.38
8.05%
Healthequity Inc
Healthequity Inc
Buy
$6.7B
-8.24%
84.29
7.71%

Insights on Certara Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 85.57M → 96.65M (in $), with an average increase of 5.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -48.96M → -4.68M (in $), with an average increase of 229.5% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 16.9% return, outperforming this stock by 33.9%

  • Vs HQY

    In the last 3 years, Certara Inc has experienced a drawdown of -36.7%, however Healthequity Inc resisted the overall trend and outperformed by 33.7%

Institutional Holdings

  • BlackRock Inc

    8.70%
  • Vanguard Group Inc

    7.81%
  • Mubadala Investment Company PJSC

    5.98%
  • Baillie Gifford & Co Limited.

    5.31%
  • William Blair Investment Management, LLC

    3.56%
  • Wasatch Advisors LP

    3.06%

Company Information

certara is a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. certara’s solutions, which span the drug development and patient care lifecycle, help increase the probability of regulatory and commercial success by using the most scientifically advanced modeling and simulation technologies and regulatory strategies. its clients include hundreds of global biopharmaceutical companies, leading academic institutions and key regulatory agencies. for more information, visit www.certara.com.

Organization
Certara Inc
Employees
1338
CEO
Dr. William F. Feehery Ph.D.
Industry
Healthcare

FAQs